Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.56 USD | -5.97% | +0.67% | -6.22% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.22% | 209M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.53% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- B. Riley Lowers INmune Bio's Price Target to $14 from $20, Notes Higher Cost of Capital; Keeps Buy Rating